The TLR pathway is activated in APS patients, in which peripheral mononuclear cells show a significant increase in the gene expression of TLR2 and TLR4 that mediate aPL-induced vascular abnormalities (25). This evidence concerns the gene TLR4 and autoimmune polyendocrinopathy.